α-Adrenoreceptor Reagents. 2. Effects of Modification of the 1, 4-Benzodioxan Ring System on α-Adrenoreceptor Activity

Journal of Medicinal Chemistry

Volumn 27, Issue 5, 1984, Pages 570-576

  Chapleo, Christopher B ^a   Myers, Peter L ^a   Butler, Richard C M ^a   Davis, John A ^a   Doxey, John C ^a   Higgins, Stanley D ^a   Myers, Malcolm ^a   Roach, Alan G ^a   Smith, Colin F C ^a   Stillings, Michael R ^a   Welbourn, Anthony P ^a  

^a Reckitt & Colman   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

1,4 BENZODIOXAN DERIVATIVE; 2 (2,3 DIHYDRO 2 BENZOFURANYL) 2 IMIDAZOLINE; 2 (2,3 DIHYDRO 2 BENZOFURANYL) 2 IMIDAZOLINE DERIVATIVE; ALPHA ADRENERGIC RECEPTOR; ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT; ALPHA ADRENERGIC RECEPTOR STIMULATING AGENT; CLONIDINE; IDAZOXAN; IDAZOXAN DERIVATIVE; NEW DRUG; PHENYLEPHRINE; UNCLASSIFIED DRUG; YOHIMBINE;

ANIMAL CELL; ANOCOCCYGEUS MUSCLE; ARTICLE; DOSE RESPONSE; DRUG ANALYSIS; DRUG ANTAGONISM; DRUG COMPARISON; DRUG IDENTIFICATION; DRUG RECEPTOR BINDING; DRUG RESPONSE; DRUG SCREENING; DRUG SYNTHESIS; GREAT BLOOD VESSEL; INTRAVENOUS DRUG ADMINISTRATION; MALE GENITAL SYSTEM; MOUSE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE; ORAL DRUG ADMINISTRATION; PHARMACOKINETICS; RAT; STRUCTURE ACTIVITY RELATION; VAS DEFERENS;

ADRENERGIC ALPHA-ANTAGONISTS; ANIMALS; DIOXANES; DIOXINS; IDAZOXAN; INDICATORS AND REAGENTS; MALE; MICE; MUSCLES; PHENYLEPHRINE; RATS; RATS, INBRED STRAINS; RECEPTORS, ADRENERGIC, ALPHA; STRUCTURE-ACTIVITY RELATIONSHIP; SYNAPSES; VAS DEFERENS;

EID: 0021326394     PISSN: 00222623     EISSN: 15204804     Source Type: Journal    
DOI: 10.1021/jm00371a003     Document Type: Article

References (23)

1. Chapleo, C. B.; Myers, P. L.; Butler, R. C. M.; Doxey, J. C., Roach, A. G.; Smith, C. F. C. J. Med. Chem. 1983, 26, 823.
2. Krapcho, J.; Lott, W. A. U.S. Patent 2979 511.
3. Chapleo, C. B.; Myers, P. L. Tetrahedron Lett. 1981, 22, 4839.
4. Chapleo, C. B.; Myers, P. L. British Patent 2068476.
5. Christiansen, W. G.; Dolliver, M. A. J. Am. Chem. Soc. 1944, 66, 312.
6. Geigy, J. R. Belgium Patent 613 210.
7. Witiak, D. T.; Stratford, E. S.; Nazareth, R.; Wagner, G.; Feller, D. F. J. Med. Chem. 1971, 14, 758.
8. Rene, L.; Royer, R. Eur. J. Med. Chem. Chim. Ther. 1975, 10, 72.
9. Rene, L.; Royer, R. Bull. Soc. Chim. Fr. 1975, 9-10, 2345.
10. Druey, J.; Tripod, J. Med. Chem. (Academic) 1967, 7.
11. Witiak, D. T.; Carr, J. B.; Mersmann, H. J. U.S. Patent 2007973.
12. Doxey, J. C. Eur. J. Pharmacol. 1979, 54, 185.
13. Doxey, J. C.; Smith, C. F. C.; Walker, J. M. Br. J. Pharmacol. 1977, 60, 91.
14. Chapleo, C. B.; Doxey, J. C.; Myers, P. L.; Roach, A. G. Br. J. Pharmacol. 1981, 74, 842P.
15. Doxey, J. C.; Everitt, J. Br. J. Pharmacol. 1977, 61, 559.
16. Roach, A. G.; Doxey, J. C.; Berridge, T. L. Fed. Proc., Fed. Am. Soc. Exp. Biol. 1983, 42, 636.
17. Arunlakshana, O.; Schild, H. O. Br. J. Pharmacol. Chemother. 1959, 14, 48.
18. Berridge, T. L.; Gadie, B.; Roach, A. G.; Tulloch, I. F. Br. J. Pharmacol. 1983, 78, 507.
19. Tulloch, I. F., unpublished result
20. Rao, C. S.; Taneja, V. Indian J. Chem. 1979, 18B, 254.
21. Shirley, D. A.; Cameron, M. D. J. Am. Chem. Soc. 1950, 72, 2788; 1952, 74, 664.
22. Fredga, A. Acto Chem. Scand. 1955, 9, 719.
23. Bowden, K.; Heilbron, I. M.; Jones, E. R. H.; Weedon, B. C. L. J. Chem. Soc. 1946, 39.